Abstract
To the Editor: In their excellent review article on Hodgkin's disease (March 5 issue),1 Urba and Longo recommend that radiotherapy should be delivered only by an experienced radiation oncologist because the “treatment outcome may vary in relation to the radiation oncologist's degree of experience.” They do not make comparable recommendations for the administration of combination chemotherapy. However, it is highly unlikely that the medical oncologist's experience will not influence treatment results. Moreover, acute life-threatening toxicity is as frequent or more frequent after chemotherapy than after radiotherapy. We would therefore recommend that the medical oncologist who treats a patient with Hodgkin's…
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | New England Journal of Medicine |
| Jahrgang | 327 |
| Ausgabenummer | 7 |
| Seiten (von - bis) | 499-500 |
| Seitenumfang | 2 |
| ISSN | 0028-4793 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 13.08.1992 |
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
Fingerprint
Untersuchen Sie die Forschungsthemen von „Hodgkin's Disease“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver